Rakshamani Tripathi

Years Active: 2018-2023
Publications (10 Years): 4

University of Kentucky

National Institute of Immunology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kentucky Jan 23 2014

United States

Post Doc :: Department of Pharmacology and Nutritional Sciences

Education History

National Institute of Immunology Jul 05 2007 - Jan 18 2014

India

PHD :: Cell Death and Differentiation Research Lab

Publications

Anastasia Lyon, Rakshamani Tripathi, Christina Meeks, Daheng He, Yuanyuan Wu, Jinpeng Liu, Chi Wang, Jing Chen, Haining Zhu, Sujata Mukherjee, Saptadwipa Ganguly, Rina Plattner
ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. Cancers 15 (3) (2023)
Anastasia Lyon, Rakshamani Tripathi, Christina Meeks, Daheng He, Yuanyuan Wu, Jinpeng Liu, Chi Wang, Jing Chen, Haining Zhu, Sujata Mukherjee, Saptadwipa Ganguly, Rina Plattner
ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. Cancers 15 (3) (2023)
Rakshamani Tripathi, Zulong Liu, Aditi Jain, Anastasia Lyon, Christina Meeks, Dana Richards, Jinpeng Liu, Daheng He, Chi Wang, Marika Nespi, Andrey Rymar, Peng Wang, Melissa A Wilson, Rina Plattner
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling. Nature communications 11 (1) (2020)
Rakshamani Tripathi, Leann S Fiore, Dana L Richards, Yuchen Yang, Jinpeng Liu, Chi Wang, Rina Plattner
Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis. Science signaling 11 (518) (2018)

Rakshamani Tripathi.css-eqlu8i{font-size:small;padding-left:4px;}